Abstract
Immunotherapy of childhood malignancies has a magic aura of promising an easy way to cure. It is not only the public, but also the medical community, which has caused this hope. Therefore, it was worthwhile to bring together a panel of experts working in the field of immunotherapy in order to discuss ongoing projects, and to show hopes and disappointments. The result was a fascinating symposium sponsored by The Kind Philipp Leukemia Foundation (Mönchengladbach, Germany). The symposium took place in the Reissensburg near Ulm (Germany) which gives the ideal location for such an event.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Age Factors
-
Animals
-
Antibodies, Monoclonal / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Cancer Vaccines / administration & dosage
-
Cell Line, Tumor
-
Child
-
Clinical Trials, Phase I as Topic
-
Clinical Trials, Phase II as Topic
-
Cytokines / therapeutic use
-
Disease Models, Animal
-
Feasibility Studies
-
Genetic Therapy
-
Graft vs Leukemia Effect
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Immunologic Factors / therapeutic use
-
Immunotherapy*
-
Immunotherapy, Adoptive
-
Killer Cells, Natural / immunology
-
Leukemia / therapy
-
Mice
-
Neoplasms / therapy*
-
Peripheral Blood Stem Cell Transplantation
-
T-Lymphocytes / immunology
-
Transplantation, Homologous
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
Cancer Vaccines
-
Cytokines
-
Immunologic Factors